Xianling Dai

534 total citations
20 papers, 324 citations indexed

About

Xianling Dai is a scholar working on Epidemiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Xianling Dai has authored 20 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Molecular Biology and 6 papers in Cell Biology. Recurrent topics in Xianling Dai's work include Liver Disease Diagnosis and Treatment (10 papers), Endoplasmic Reticulum Stress and Disease (6 papers) and Diet, Metabolism, and Disease (4 papers). Xianling Dai is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Endoplasmic Reticulum Stress and Disease (6 papers) and Diet, Metabolism, and Disease (4 papers). Xianling Dai collaborates with scholars based in China and Thailand. Xianling Dai's co-authors include Qin Kuang, Minxuan Xu, Jun Tan, Bochu Wang, Liancai Zhu, Yan Sun, Chenxu Ge, Linfeng Hu, Deshuai Lou and Chenxu Ge and has published in prestigious journals such as Nature Communications, Hepatology and Journal of Hazardous Materials.

In The Last Decade

Xianling Dai

19 papers receiving 323 citations

Peers

Xianling Dai
Sha Hu China
Sang Geon Kim South Korea
Yan Zou China
Hee-Seon Park South Korea
Sha Hu China
Xianling Dai
Citations per year, relative to Xianling Dai Xianling Dai (= 1×) peers Sha Hu

Countries citing papers authored by Xianling Dai

Since Specialization
Citations

This map shows the geographic impact of Xianling Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianling Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianling Dai more than expected).

Fields of papers citing papers by Xianling Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianling Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianling Dai. The network helps show where Xianling Dai may publish in the future.

Co-authorship network of co-authors of Xianling Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xianling Dai. A scholar is included among the top collaborators of Xianling Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianling Dai. Xianling Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Bobo, Jiaqi Yu, Hongfu Sun, et al.. (2024). Targeting cancer stress-associated hyperinsulinemia and abnormal behavior mitigates lung carcinoma in postmenopausal mouse: Intervention function of peimine. Journal of Functional Foods. 121. 106400–106400. 1 indexed citations
3.
Chang, Ming‐Hui, et al.. (2024). GTPBP8 mitigates nonalcoholic steatohepatitis (NASH) by depressing hepatic oxidative stress and mitochondrial dysfunction via PGC-1α signaling. Free Radical Biology and Medicine. 229. 312–332. 3 indexed citations
4.
Xu, Minxuan, Junjie Zhao, Liancai Zhu, et al.. (2024). Targeting PYK2 with heterobifunctional T6BP helps mitigate MASLD and MASH-HCC progression. Journal of Hepatology. 82(2). 277–300. 4 indexed citations
5.
Li, Xinyu, et al.. (2024). Palmitoyltransferase ZDHHC6 promotes colon tumorigenesis by targeting PPARγ-driven lipid biosynthesis via regulating lipidome metabolic reprogramming. Journal of Experimental & Clinical Cancer Research. 43(1). 227–227. 17 indexed citations
6.
Xu, Minxuan, Jun Tan, Liancai Zhu, et al.. (2023). Palmitoyltransferase ZDHHC3 Aggravates Nonalcoholic Steatohepatitis by Targeting S‐Palmitoylated IRHOM2. Advanced Science. 10(28). e2302130–e2302130. 13 indexed citations
7.
Luo, Jing, Jun Tan, Junjie Zhao, et al.. (2022). Cynapanoside A exerts protective effects against obesity-induced diabetic nephropathy through ameliorating TRIM31-mediated inflammation, lipid synthesis and fibrosis. International Immunopharmacology. 113(Pt B). 109395–109395. 4 indexed citations
8.
Ge, Chenxu, Jun Tan, Xianling Dai, et al.. (2022). Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK. Nature Communications. 13(1). 5945–5945. 41 indexed citations
9.
Xu, Minxuan, Jun Tan, Liancai Zhu, et al.. (2022). The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway. Acta Pharmaceutica Sinica B. 13(3). 1071–1092. 16 indexed citations
10.
Ge, Chenxu, Jun Tan, Deshuai Lou, et al.. (2022). Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling. Redox Biology. 51. 102274–102274. 65 indexed citations
12.
Dai, Xianling, Qin Kuang, Yan Sun, et al.. (2022). Fisetin represses oxidative stress and mitochondrial dysfunction in NAFLD through suppressing GRP78-mediated endoplasmic reticulum (ER) stress. Journal of Functional Foods. 90. 104954–104954. 18 indexed citations
13.
Kuang, Qin, et al.. (2022). Deficiency in Inactive Rhomboid Protein2 (iRhom2) Alleviates Alcoholic Liver Fibrosis by Suppressing Inflammation and Oxidative Stress. International Journal of Molecular Sciences. 23(14). 7701–7701. 5 indexed citations
14.
Li, Qiang, Chenxu Ge, Jun Tan, et al.. (2021). Juglanin protects against high fat diet-induced renal injury by suppressing inflammation and dyslipidemia via regulating NF-κB/HDAC3 signaling. International Immunopharmacology. 95. 107340–107340. 23 indexed citations
15.
Li, Ling, Linfeng Hu, Qiang Li, et al.. (2021). Carminic acid mitigates fructose-triggered hepatic steatosis by inhibition of oxidative stress and inflammatory reaction. Biomedicine & Pharmacotherapy. 145. 112404–112404. 17 indexed citations
16.
Dai, Xianling, Qin Kuang, Linfeng Hu, et al.. (2021). Fisetin protects against high fat diet-induced nephropathy by inhibiting inflammation and oxidative stress via the blockage of iRhom2/NF-κB signaling. International Immunopharmacology. 92. 107353–107353. 27 indexed citations
17.
Dai, Xianling, Qin Kuang, Qiang Li, et al.. (2021). Betacyanins attenuates diabetic nephropathy in mice by inhibiting fibrosis and oxidative stress via the improvement of Nrf2 signaling. Journal of Functional Foods. 81. 104403–104403. 7 indexed citations
18.
Xu, Minxuan, Xianling Dai, Qin Kuang, et al.. (2020). Dysfunctional Rhbdf2 of proopiomelanocortin mitigates ambient particulate matter exposure-induced neurological injury and neuron loss by antagonizing oxidative stress and inflammatory reaction. Journal of Hazardous Materials. 400. 123158–123158. 8 indexed citations
19.
Hu, Linfeng, Jing Feng, Xianling Dai, et al.. (2019). Oral flavonoid fisetin treatment protects against prolonged high-fat-diet-induced cardiac dysfunction by regulation of multicombined signaling. The Journal of Nutritional Biochemistry. 77. 108253–108253. 21 indexed citations
20.
Xu, Minxuan, Yan Sun, Xianling Dai, et al.. (2018). Fisetin attenuates high fat diet-triggered hepatic lipid accumulation: A mechanism involving liver inflammation overload associated TACE/TNF-α pathway. Journal of Functional Foods. 53. 7–21. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026